4-(2,7-Dichloropyrido[2,3-d]pyrimidin-4-yl)morpholine

Catalog No.: 
ACNEGA802
CAS No.: 
938443-21-1
Molecular Formula: 
C11H10Cl2N4O
Molecular Weight: 
285.13
4-(2,7-Dichloropyrido[2,3-d]pyrimidin-4-yl)morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$374.00InquiryInquiry
250mg97%$678.00InquiryInquiry
1g97%$2024.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2,7-Dichloropyrido[2,3-d]pyrimidin-4-yl)morpholine
IUPAC Name4-(2,7-dichloropyrido[2,3-d]pyrimidin-4-yl)morpholine
MDL No.MFCD13181198
Molecular FormulaC11H10Cl2N4O
Molecular Weight285.13
SMILESClC1=NC2=C(C=C1)C(=NC(Cl)=N2)N1CCOCC1
InChI KeyLMWIZPCKEPDNLP-UHFFFAOYSA-N
Synonym4-(2,7-dichloropyrido[2,3-d]pyriMidin-4-yl)Morpholine;Pyrido[2,3-d]pyriMidine, 2,7-dichloro-4-(4-Morpholinyl)-
CAS No.938443-21-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNEGA802 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPAUI932 route compound structure diagram
    ACPAUI932938443-20-0In Stock
  2. Then
  3. ACNEGA802 route product structure diagram
    ACNEGA802938443-21-1
Inquiry

2. ACNEGA802 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPAUI932 route compound structure diagram
    ACPAUI932938443-20-0In Stock
  4. Then
  5. ACNEGA802 route product structure diagram
    ACNEGA802938443-21-1
Inquiry

3. ACNEGA802 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNEGA802 route product structure diagram
    ACNEGA802938443-21-1
Inquiry

Comments (0)